Please use this identifier to cite or link to this item: https://doi.org/10.3390/ijms19082362
Title: Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer
Authors: Ranaware A.M.
Banik K.
Deshpande V.
Padmavathi G.
Roy N.K.
Sethi G. 
Fan L.
Kumar A.P. 
Kunnumakkara A.B.
Keywords: Cancer
Chemoresistance
Magnolol
Molecular targets
Phytochemicals
Issue Date: 2018
Publisher: MDPI AG
Citation: Ranaware A.M., Banik K., Deshpande V., Padmavathi G., Roy N.K., Sethi G., Fan L., Kumar A.P., Kunnumakkara A.B. (2018). Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer. International Journal of Molecular Sciences 19 (8) : 2362. ScholarBank@NUS Repository. https://doi.org/10.3390/ijms19082362
Abstract: The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discovering novel economic and patient friendly drugs that are safe and efficacious is warranted. Several natural compounds have proved their potential against this dreadful disease so far. Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree. Magnolol can efficiently prevent or inhibit the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. Considering these perspectives, the current review primarily focuses on the fascinating role of magnolol against various types of cancers, and the source and chemistry of magnolol and the molecular mechanism underlying the targets of magnolol are discussed. This review proposes magnolol as a suitable candidate that can be appropriately designed and established into a potent anti-cancer drug. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: International Journal of Molecular Sciences
URI: http://scholarbank.nus.edu.sg/handle/10635/152149
ISSN: 16616596
DOI: 10.3390/ijms19082362
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ijms19082362.pdf1.2 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

15
checked on Jan 21, 2020

Page view(s)

68
checked on Jan 24, 2020

Download(s)

1
checked on Jan 24, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.